Evaxion Biotech's total assets for Q2 2025 were $22.45M, a decrease of -11.05% from the previous quarter. EVAX total liabilities were $16.22M for the fiscal quarter, a 8.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.